- Home
- KRMD vs ZTO Comparison
KRMD vs ZTO Comparison
Compare KRMD & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- ZTO
- Stock Information
- Founded
- KRMD 1980
- ZTO 2002
- Country
- KRMD United States
- ZTO China
- Employees
- KRMD N/A
- ZTO N/A
- Industry
- KRMD Medical/Dental Instruments
- ZTO Advertising
- Sector
- KRMD Health Care
- ZTO Consumer Discretionary
- Exchange
- KRMD Nasdaq
- ZTO Nasdaq
- Market Cap
- KRMD 126.9M
- ZTO N/A
- IPO Year
- KRMD N/A
- ZTO 2016
- Fundamental
- Price
- KRMD $3.12
- ZTO $18.69
- Analyst Decision
- KRMD Strong Buy
- ZTO Buy
- Analyst Count
- KRMD 4
- ZTO 4
- Target Price
- KRMD $4.63
- ZTO $25.13
- AVG Volume (30 Days)
- KRMD 118.8K
- ZTO 2.5M
- Earning Date
- KRMD 05-07-2025
- ZTO 05-20-2025
- Dividend Yield
- KRMD N/A
- ZTO 3.65%
- EPS Growth
- KRMD N/A
- ZTO N/A
- EPS
- KRMD N/A
- ZTO 1.12
- Revenue
- KRMD $35,083,740.00
- ZTO $6,066,599,984.00
- Revenue This Year
- KRMD $16.50
- ZTO $18.23
- Revenue Next Year
- KRMD $15.47
- ZTO $12.96
- P/E Ratio
- KRMD N/A
- ZTO $16.86
- Revenue Growth
- KRMD 19.65
- ZTO 15.26
- 52 Week Low
- KRMD $1.86
- ZTO $16.34
- 52 Week High
- KRMD $5.05
- ZTO $27.50
- Technical
- Relative Strength Index (RSI)
- KRMD 69.32
- ZTO 47.77
- Support Level
- KRMD $2.51
- ZTO $18.56
- Resistance Level
- KRMD $3.35
- ZTO $19.21
- Average True Range (ATR)
- KRMD 0.18
- ZTO 0.46
- MACD
- KRMD 0.10
- ZTO 0.05
- Stochastic Oscillator
- KRMD 90.65
- ZTO 39.73
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).